Vyriad Alternatives & Competitors

12 companies similar to Vyriad — Vyriad is a clinical-stage biotech company developing targeted genetic therapies...

SOLID Therapeutics

An early-stage oncology company aiming to treat solid tumors

5 Unknown

Denmark

Synamics Therapeutics

AI-powered therapeutics for treatment-resistant cancer

7 Seed $4.10M

Beverly Hills, United Sta...

Biotechnology Pharmaceutical

Symic Bio

A new category of therapeutics based on extracellular matrix biology

2 Series C $84.15M

San Francisco, United Sta...

Biotechnology Health Care

Areteia Therapeutics

Pioneering a new era in asthma control

10 Series A $425.00M

United States

Track all Vyriad competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

METiS Therapeutics

Redefining drug discovery and delivery with a data-driven platform to develop best-in-clas...

30 Series D $491.50M

Cambridge, United States

Meliora Therapeutics

Our goal is to develop life-saving cancer therapies using cutting-edge science and machine...

7 Seed $11.00M

San Francisco, United Sta...

Biotechnology Health and Wellness

Deciphex

Transforming Pathology using Tailored Workflows and Artificial Intelligence

186 Series C $84.27M

Ireland

AI Biotechnology +1

Current Health

Deliver complex care and specialty therapies beyond the hospital.

137 Acquired $466.60M

Boston, United States

Health Care Medical Devices

C3 | Clinical Consulting Consortium

C3 is a woman-owned niche CRO with an extensive network of highly experienced CRAs in vari...

Savannah, United States

Analytics Health Care +2

Pikralida

Pikralida - A drug development company

20 Unknown $16.70M

Poznan, Poland

Xegen

Biostatistics & Bioinformatics company specialized in Next Generation Sequecing data analy...

3 Seed

France

Biotechnology Clean Energy

Likarda, Inc.

Transforming How Cell Therapies, Biologics, Peptides, and Hormones Are Delivered

14 Unknown $4.60M

Kansas City, United State...

Biotechnology Health and Wellness +1

About Vyriad

Vyriad is a clinical-stage biotech company developing targeted genetic therapies that deliver genes directly to cells.

Services

Development of Viral Platforms, Manufacturing of Genetic Therapies, Preclinical and Clinical Trial Management, Collaborative Research and Development

Target Customers

Medical Institutions, Pharmaceutical Companies, Research Organizations, Healthcare Organizations

Taxonomy

Biotech, Genetic Therapies, Oncolytic Virotherapy, Viral Vectors, Gene Editing, Cancer Treatment, Phase 1-2 Clinical Studies, Targeted Cell Therapy, Immuno-Oncology, Clinical Research Collaboration, Proprietary Oncolytic Virus, Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Squamous Cell Carcinoma

Business Model

B2B

Revenue Model

Licensing, Performance Based, Project Based

Frequently Asked Questions

Top alternatives to Vyriad include SOLID Therapeutics, Synamics Therapeutics, Symic Bio, Areteia Therapeutics, METiS Therapeutics . These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Vyriad based on industry overlap, target customers, and business model.

Vyriad is a clinical-stage biotech company developing targeted genetic therapies that deliver genes directly to cells.

Don't just read about them. Follow them.

BounceWatch watches Vyriad and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Vyriad Profile SOLID Therapeutics Alternatives Synamics Therapeutics Alternatives Symic Bio Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Vyriad on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.